Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ATG-012 |
| Trade Name | |
| Synonyms | ATG 012|ATG012 |
| Drug Descriptions |
ATG-012 inhibits KRAS G12C, potentially resulting in inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2679). |
| DrugClasses | KRAS G12C inhibitor 36 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ATG-012 | ATG-012 | 0 | 0 |
| ATG-012 + AZD0364 | ATG-012 AZD0364 | 0 | 0 |
| ATG-012 + ET0038 | ATG-012 ET0038 | 0 | 0 |
| ATG-012 + Onatasertib | ATG-012 Onatasertib | 0 | 0 |
| ATG-012 + Selinexor | ATG-012 Selinexor | 0 | 0 |